太龙药业龙虎榜数据（12月10日）

Core Viewpoint - TaiLong Pharmaceutical (600222) experienced a significant decline of 9.15% in its stock price, with a trading volume of 5.66 billion yuan and a turnover rate of 13.00% on the day of reporting [2] Group 1: Stock Performance - The stock's price drop was attributed to a deviation of -8.91% from the daily limit, leading to its listing on the Shanghai Stock Exchange [2] - The stock saw a trading fluctuation of 5.27% throughout the day [2] Group 2: Institutional Activity - Institutional investors net sold 740.08 thousand yuan, while total net selling from brokerage seats amounted to 105.07 thousand yuan [2] - The top five brokerage seats accounted for a total transaction volume of 89.06 million yuan, with buying transactions at 40.30 million yuan and selling transactions at 48.75 million yuan, resulting in a net selling of 845.16 thousand yuan [2] Group 3: Capital Flow - The stock experienced a net outflow of 55.65 million yuan in principal funds, with large orders contributing to a net outflow of 35.34 million yuan and big orders contributing to a net outflow of 20.31 million yuan [2] - Over the past five days, the total net outflow of principal funds reached 246 million yuan [2] Group 4: Financial Performance - For the first three quarters, TaiLong Pharmaceutical reported a total revenue of 1.187 billion yuan, reflecting a year-on-year decrease of 11.47% [2] - The net profit for the same period was 25.33 million yuan, which represents a year-on-year decline of 12.36% [2]